MSDS

Page 4 / 8
Skin and body protection
Wear long-sleeved shirt, long pants, socks, shoes, and gloves.
Hand protection
Protective gloves
Hygiene measures
Clean water should be available for washing in case of eye or skin contamination. Wash skin prior to
eating, drinking, chewing gum or using tobacco. Shower or bathe at the end of working.
9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
Appearance
solid granules
Physical state
solid
Odor
No information available.
pH
7.33
Melting Point/Range
No information available.
Freezing point
No information available.
Boiling Point/Range
Not applicable
Flash Point
Not applicable
Evaporation rate
Not applicable
Flammable properties
Powdered material may form explosive dust-air mixtures
Vapor pressure
No information available.
Vapor density
No information available.
Density
0.77-0.83 g/cm³
Water solubility
No information available
Percent volatile
No information available.
Partition coefficient:
Not applicable
Viscosity
No information available.
10. STABILITY AND REACTIVITY
Stability
Stable under recommended storage conditions.
Conditions to avoid
Heat, flames and sparks
Hazardous decomposition products
Carbon oxides. Hydrogen chloride. Hydrogen fluoride.
Hazardous polymerization
Hazardous polymerization does not occur.
11. TOXICOLOGICAL INFORMATION
Acute effects
Acute Toxicity
Large doses of bifenthrin ingested by laboratory animals produced signs of toxicity including convulsions, tremors and bloody
nasal discharge.
Bifenthrin
does not cause acute delayed neurotoxicity. Experience to date indicates that contact with bifenthrin may occasionally produce skin
sensations such as rashes, numbing, burning or tingling. These sensations are reversible and usually subside within 12 ho
urs.
Large doses of zeta
-
cypermethrin, ingested by laboratory animals, may produce signs of toxicity including tremors, incoordination, convulsions,
staggered gait, and oral discharge.
Eye contact
Mild irritant
Skin contact
Slightly or non-irritating (rabbit)
LD50 Dermal
> 5000 mg/kg (Rat)
LD50 Oral
727.3 mg/kg (Rat) (Based on a similar product)
LC50 Inhalation:
> 2.11 mg/L 4 hr (Rat)
Sensitization
Sensitizer
Chronic effects